Is lipid signaling through cannabinoid 2 receptors part of a protective system?
about
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?Marijuana use and long-term mortality among survivors of acute myocardial infarctionModulation of cellular redox homeostasis by the endocannabinoid systemEndocannabinoids in neuroendopsychology: multiphasic control of mitochondrial functionExpression of functional cannabinoid CB2 receptor in VTA dopamine neurons in ratsRegulation of nausea and vomiting by cannabinoids and the endocannabinoid systemEmerging therapeutic targets of sepsis-associated acute kidney injury.Role of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationEndocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.Peripheral gating of pain signals by endogenous lipid mediators.Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicityCB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat.Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis.Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Molecular pathways in non-alcoholic fatty liver disease.Cnr2 deficiency confers resistance to inflammation-induced preterm birth in mice.Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.Marijuana: respiratory tract effects.Methods for recombinant expression and functional characterization of human cannabinoid receptor CB2.Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features.Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice.Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitisCannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.Trisubstituted Sulfonamides: a New Chemotype for Development of Potent and Selective CB2 Receptor Inverse Agonists.The endocannabinoid system and cancer: therapeutic implication.Endocannabinoid signaling at the periphery: 50 years after THC.Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptorsAnti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Miceβ-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potencyThe activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsAlcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic PotentialsΔ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injuryTargeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.
P2860
Q21093231-91573397-B6AF-41F1-99CA-402561084ABBQ24629571-64D8EA17-447A-4141-990E-5493590FA679Q26744211-D4629A05-F911-4453-B97B-C1B9FC0A0E09Q26852356-3A3C827F-FC09-4A6C-9A02-6A68844AE669Q28272826-533D8363-162D-421C-A4AD-98C553541A45Q28301264-C94DE082-4C6E-4346-9622-25C8B4DA87FFQ30300333-865EDDFD-003D-476A-B971-1381EA28B962Q30357558-6CBC46EC-1DD7-4A0A-B635-F64917B80673Q33597839-BA805DCF-450E-4287-A070-AD043EA0C226Q33608432-90282000-3D0A-454B-BC25-9094EE764D2EQ33636763-C77353D0-F8F7-4732-9CDC-33B6BB643DD0Q33638542-3B9B8CB8-D3DE-4131-B56A-87E1E5FE10F5Q33745557-C21D4032-FB83-49F3-BF75-F70CE3ABF89FQ33746277-24E10C34-A80F-4624-89A3-CD0E692636D5Q33819365-5777D5CA-ADF6-4BBE-80EA-F345CBD21EDAQ33890230-955583E1-7985-4DC7-AA09-26AD6C7B25A5Q34185758-55BBF712-6FEA-4E07-9A69-E0601F2D7230Q34294075-998C6FE1-E28C-4FAE-9A81-3582C844D7DEQ34339177-C30D6D27-2FE6-4673-82EA-3EF1F20DC25CQ34347280-69B6CFD2-E3D9-4ADB-A9FF-5A8C3F90A34BQ34413054-BC652A6B-F147-4A13-A388-69F82566EA09Q34502788-78DC4709-F567-45C5-BA8E-3C031D1F4C35Q34534443-42A6A283-2106-4F5B-BFBB-380027DAD6E4Q34565750-1FB7AFE5-7541-4EE5-AD1F-24D0132A0131Q34851941-C82C6A6D-451F-4E34-8729-ED83E74C3E68Q35147183-5779E96B-7EFA-4AC8-99FA-C0DED60F54D0Q35193299-BF10FD29-B0A7-4E1E-B1ED-6EE91B5D550FQ35572176-77A9366E-3AD5-4FA2-A84C-458ABD67A95BQ35784024-25BF4815-EA3F-40BB-8706-DB8EDD2E3A18Q35807657-C1332F3C-6985-4001-B6E4-50AA18AE8D01Q35847290-D4124C39-0888-4D5D-92A1-77B1AAE16358Q35854652-4A64B454-B2C0-4664-A0FA-F5B8A9A44212Q35865677-2C0366E3-E3A3-42B8-B797-86FC1174488BQ35937792-40001022-DF24-4890-A252-E96274FDD5BCQ35951992-DF3E1DF4-D5C5-46DD-850B-1266869225E6Q36165438-7924E22C-3A51-4480-9666-19F996EBD034Q36176486-A6480B15-717D-4E15-B8CD-9C71D54E9759Q36176499-C1164AE4-D608-443B-A486-EEC4BBC4C7ACQ36346915-D6F2D4FA-4558-4948-BACD-BE278FA21A3BQ36506869-46210A97-DFC1-446A-8A12-D1549CD0F4D4
P2860
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@ast
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@en
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@nl
type
label
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@ast
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@en
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@nl
prefLabel
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@ast
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@en
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@nl
P2860
P921
P3181
P1476
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
@en
P2860
P304
P3181
P356
10.1016/J.PLIPRES.2011.01.001
P407
P577
2011-04-01T00:00:00Z